Cloud-Clone touts epinephrine ELISA for harder-to-measure stress biomarker

Cloud-Clone Corp. says its new Epinephrine (EPI) ELISA kit is designed to improve measurement of a key stress hormone that is easy to degrade and hard to separate from similar catecholamines. The company says the kit is aimed at researchers studying cardiovascular disease, stress, endocrinology, sports medicine and drug screening.

Why it matters: - Epinephrine is a core biomarker for stress, cardiovascular function, neuropsychiatry, sports science and endocrinology. - Accurate measurement matters because EPI levels can reflect disease severity, stress responses and drug effects. - Standard assays often struggle with oxidation, cross-reactivity and complex biological samples.

What happened: - Cloud-Clone Corp. introduced an Epinephrine (EPI) ELISA kit, Cat. No. CEA858Ge, for research use. - The company positioned the kit as a way to measure EPI more reliably in human and animal samples. - Cloud-Clone said the kit is intended for stress-focused biomedical research and broader life-science workflows.

The details: - EPI is produced mainly by chromaffin cells in the adrenal medulla, with smaller amounts made by sympathetic nerve terminals. - The hormone is rapidly broken down by monoamine oxidase and catechol-O-methyltransferase. - EPI can be affected by light, oxygen, temperature shifts, pH changes and repeated freeze-thaw cycles. - Dopamine and norepinephrine can interfere with EPI measurements because of structural similarity. - Cloud-Clone says the kit uses a high-specificity recognition system designed to reduce cross-reactivity with dopamine, norepinephrine and related metabolites. - The company says the kit includes anti-oxidative buffers intended to preserve EPI activity during dilution, incubation and reaction steps. - Cloud-Clone says the assay offers high sensitivity and a broad linear range to detect subtle changes in EPI. - The kit supports human, rat, mouse and rabbit samples. - Compatible sample types include serum, plasma, adrenal, myocardial and brain tissue homogenates, cell culture supernatant, urine and cerebrospinal fluid. - The workflow uses routine centrifugation and dilution, with no complex extraction or derivatization required. - Cloud-Clone says complete assays finish within three hours on a detachable 96-well plate using ready-to-use reagents. - The company says the kit is designed for batch testing, small mechanistic studies and larger drug-screening projects.

Between the lines: - The launch targets a common research pain point: many EPI methods are either highly accurate but slow and expensive, or easy to run but too prone to interference. - ELISA is the practical middle ground for many labs, but generic kits can under-read EPI when oxidation or cross-reactivity is not controlled. - Cloud-Clone is betting that tighter chemistry and workflow simplicity will make the assay more useful in routine research settings.

What's next: - Cloud-Clone says researchers can request product specifications and technical support through its global communication channels. - The company says it will continue expanding detection products for hormones, neurotransmitters and cytokines. - Researchers using the kit will likely test whether the assay improves reproducibility and detection of small EPI shifts in real-world sample sets.

The bottom line: - Cloud-Clone is pitching its EPI ELISA as a faster, more stable option for labs that need routine epinephrine data without the cost and complexity of chromatography or mass spectrometry.

More information: Cloud-Clone Corp. - LinkedIn: Cloud-Clone Corp. - Instagram: Cloud-Clone Corp. - TikTok: Cloud-Clone Corp. - X: Cloud-Clone Corp.